<table id="ID112" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col width="34%"></col>
<col width="33%"></col>
<col width="33%"></col>
<thead>
<tr>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Effect </content>
<content stylecode="bold">on </content>
<content stylecode="bold">Concentration </content>
<content stylecode="bold">of </content>
<content stylecode="bold">Lamotrigine </content>
<content stylecode="bold">or </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Clinical </content>
<content stylecode="bold">Comment </content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="3">
<paragraph></paragraph>
<paragraph stylecode="Footnote">↓= Decreased (induces lamotrigine gluronidation). <br/>
</paragraph>
<paragraph stylecode="Footnote">↑= Increased (inhibits lamotrigine glucuronidation).<br/>
</paragraph>
<paragraph stylecode="Footnote">?= Conflicting data.<br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Estrogen-containing oral <br/>contraceptive preparations <br/>containing 30 mcg ethinylestradiol <br/>and 150 mcg levonorgestrel<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>
<br/>
<br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">Decreased lamotrigine levels <br/>approximately 50%.<br/>
<br/>
<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">↓ levonorgestrel<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">Decrease in levonorgestrel component by 19%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Carbamazepine (CBZ) and <br/>CBZ epoxide<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">Addition of carbamazepine decreases lamotrigine <br/>concentration approximately 40%.<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">? CBZ epoxide<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">May increase CBZ epoxide levels<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenobarbital/Primidone<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine <br/>concentration approximately 40%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenytoin (PHT)<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine <br/>concentration approximately 40%<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Rifampin<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine AUC <br/>approximately 40%<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Valproate<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">↑ lamotrigine<br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">Increased lamotrigine concentrations slightly <br/>more than 2-fold.<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">? valproate<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">Decreased valproate concentrations an average of <br/>25% over a 3-week period then stabilized in healthy volunteers; <br/>no change in controlled clinical trials in epilepsy patients.<br/>
<br/>
</td>
</tr>
</tbody>
</table>